Home
Conditions
Rotavirus Infections

Clinical trial condition

Rotavirus Infections

Explore clinical trials studying Rotavirus Infections. Study availability and eligibility vary by location and protocol.

19 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Rotavirus Infections trial results

Active, not recruiting

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

NCT06962904

Conditions: Infections, RNA Virus Infections, Reoviridae Infections, +2 more
Locations: Emory Children's Center - Vaccine Research Clinic Atlanta, Georgia, United States

View Trial Details

Active, not recruiting

Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers

NCT05621655

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +6 more
Locations: Shangqiu Liangyuan District Center for Disease Control and Prevention Shangqiu, Henan, China

Ningling County Center for Disease Control and Prevention Shangqiu, Henan, China

View Trial Details

Completed

CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

NCT06485258

Conditions: Infections, RNA Virus Infections, Reoviridae Infections, +2 more
Locations: Emory Children's Center - Vaccine Research Clinic Atlanta, Georgia, United States

View Trial Details

Completed

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance

NCT03313128

Conditions: Enteric Infections, Environmental Enteric Dysfunction, Infections, +4 more
Locations: Centro de Investigação em Saúde da Polana Caniço (CISPOC) Maputo, Mozambique

View Trial Details

Completed

A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine

NCT03483116

Conditions: Infections, RNA Virus Infections, Reoviridae Infections, +2 more
Locations: Malawi-Liverpool-Wellcome Trust Clinical Research Programme Blantyre, Malawi

View Trial Details

Completed

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

NCT05037435

Conditions: Infections, RNA Virus Infections, Reoviridae Infections, +3 more
Locations: Perm State Medical University named after Academician E.A. Wagner Perm, Russia

View Trial Details

Completed

Evaluation of an Infant Immunization Encouragement Program in Nigeria

NCT03870061

Conditions: Actinomycetales Infections, Arbovirus Infections, Bacterial Infections, +55 more
Locations: Primary Health Care facilities across Jigawa State Various Cities, Jigawa State, Nigeria

Primary Health Care facilities across Katsina State Various Cities, Katsina State, Nigeria

Primary Health Care facilities across the Zamfara State Various Cities, Zamfara State, Nigeria

View Trial Details

Completed

Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study

NCT02542462

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Infections, +7 more
Locations: Cincinnati Children's Hosptital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

NCT00443846

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +15 more
Locations: Not specified

View Trial Details

Completed

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

NCT02538211

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +14 more
Locations: Academic Medical Center Amsterdam, North Holland, Netherlands

View Trial Details

Rotavirus Infections

Rotavirus Infections trial results

Related conditions